Gallbladder Adenocarcinoma Completed Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0031633 (Gallbladder Adenocarcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01825603ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by SurgeryTreatment